2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt
|
- $1270 - $2255.72
- Product name: 2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt
- CAS:
- MF: C5H3D4NaO3
- MW: 144.14
- EINECS:
- MDL Number:MFCD07784343
- Synonyms:Sodium α-ketoisovalerate-3-(methyl-13C,d2),4-13C,d2;3-(Methyl-13C,d2)-2-oxobutanoic-4-13C,d2 acid sodium salt;α-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium;α-Ketoisovaleric acid-13C2,d4 sodium salt;2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 250MG
- 250 mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberRDL0001524
- Product description2-KETO-3-(METHYL-13C,D2)-BUTYRIC ACID-4-13C,D2 SODIUM SALT 95.00%
- Packaging250MG
- Price$2255.72
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number634379
- Product description2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt 98 atom % 13C, 98 atom % D
- Packaging250mg
- Price$1270
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product number634379
- Product description2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt 98 atom % D, 98 atom % 13C
- Packaging250 mg
- Price$1330
- Updated2025-07-31
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | RDL0001524 | 2-KETO-3-(METHYL-13C,D2)-BUTYRIC ACID-4-13C,D2 SODIUM SALT 95.00% | 250MG | $2255.72 | 2021-12-16 | Buy |
| Sigma-Aldrich | 634379 | 2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt 98 atom % 13C, 98 atom % D | 250mg | $1270 | 2024-03-01 | Buy |
| Sigma-Aldrich | 634379 | 2-Keto-3-(methyl-13C,d2)-butyric acid-4-13C,d2 sodium salt 98 atom % D, 98 atom % 13C | 250 mg | $1330 | 2025-07-31 | Buy |
Properties
Melting point :227-230 °C(lit.)
form :solid
form :solid
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




